Melnite

Melatonin, the active ingredient in Melnite, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate the sleep‑wake cycle and is used to manage sleep‑related disorders in adults and adolescents.

GNH USA supplies Melnite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melnite is a melatonin receptor agonist that acts on the circadian rhythm pathway to improve sleep quality.

- Jet lag: helps adjust the internal clock after rapid time‑zone travel, reducing sleep disturbances. - Delayed sleep phase disorder: advances sleep onset time, facilitating earlier bedtime. - Primary insomnia: supports the initiation and maintenance of sleep in adults with difficulty falling or staying asleep.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often reported after ingestion. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: residual drowsiness if taken too late. - Nausea: occasional stomach upset. - Irritability: mild mood changes in some users.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling indicating hypersensitivity. - Severe depression: worsening mood in predisposed individuals. - Seizures: rare neurologic events reported in isolated cases. - Hallucinations: uncommon visual or auditory disturbances.

When considering melatonin therapy, several safety measures are recommended.

- Assess renal function: adjust use in patients with severe kidney impairment. - Avoid use in children without medical supervision: pediatric safety data are limited. - Consider timing of administration: take 30‑60 minutes before desired bedtime. - Monitor for mood changes: watch for signs of depression or anxiety. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Melatonin can interact with other medicines, altering their effects or safety profile.

Major Interactions (Avoid): - Warfarin: melatonin may increase anticoagulant effect and bleeding risk. - Cyclosporine: potential alteration of immunosuppressant levels. - Benzodiazepines: additive central nervous system depression may enhance sedation.

Moderate Interactions (Monitor Closely): - Caffeine: may diminish melatonin's sleep‑promoting effect. - Oral contraceptives: possible impact on hormone metabolism. - SSRIs (e.g., fluoxetine): may increase serotonergic activity, raising risk of serotonin‑related effects.